This post is password protected. To view it please enter your password below:
Password:
First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation.
The MiSOT-I score for solid organ transplantation.
The MiSOT-I Study: Safety and feasibility of 3rd party MAPCs for cells for immunomodulation therapy after liver transplantation.
MiSOT Fourth Meeting: lessons learned from first clinical trials.
Advancement of mesenchymal stem cell therapy in solid organ transplantation.
Toward MSC in solid organ transplantation: 2008 position paper of the MiSOT study group.
